Results 151 to 160 of about 1,029,181 (225)

Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET Study

Egger K, Bozsak R, Aicher H, Sari H, Poetzsch S, Rominger A, Martin-Soelch C, Dornbierer D, Quednow B, Scheidegger M, Cumming P.   +10 more
europepmc   +1 more source

Continuous flow synthesis of N,N-dimethyltryptamine (DMT) analogues with therapeutic potential. [PDF]

RSC Med Chem
Simoens A, Dejaegere A, Vandevelde M, Stevens CV.   +3 more
europepmc   +1 more source

Banisteriopsis caapi [PDF]

, 1998
Emmert, Susan
core   +1 more source

N,N- Dimethyltryptamine - An Endogenous Hallucinogen. [PDF]

, 1978
Barker, Steven Andrew
core   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings

Journal of Psychopharmacology, 2021
Background: N,N-dimethyltryptamine is a short-acting psychedelic tryptamine found naturally in many plants and animals. Few studies to date have addressed the neural and psychological effects of N,N-dimethyltryptamine alone, either administered ...
Carla Pallavicini, Federico Cavanna, Federico Zamberlan   +2 more
exaly   +2 more sources

“In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E. coli”

Metabolic Engineering, 2023
N,N-dimethyltryptamine (DMT), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and 5-hydroxy-N,N-dimethyltryptamine (bufotenine) are psychedelic tryptamines found naturally in both plants and animals and have shown clinical potential to help treat mental disorders, such as anxiety and depression.
Lucas M. Friedberg, Abhishek K. Sen, Quynh Nguyen, Gabriel P. Tonucci, Elle B. Hellwarth, William J. Gibbons, J. Andrew Jones   +6 more
openaire   +3 more sources

N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats

Experimental Neurology, 2020
BACKGROUND AND PURPOSE N,N-dimethyltryptamine (DMT) is an endogenous ligand of the Sigma 1 receptor (Sig-1R) with documented in vitro cytoprotective properties against hypoxia.
Attila Szabo, Alan Alpar, Zoltán G Nagy
exaly   +2 more sources

N,N-Dimethyltryptamine–Induced Psychosis

Clinical Neuropharmacology, 2015
N,N-dimethyltryptamine (DMT) is a 5-hydroxytryptamine 2A and 1A receptor agonist that exhibits potent psychoactive properties in humans. Recreational use of this drug has increased precipitously and is likely to result in an increase in patients presenting with substance-induced psychoses. The present case provides an early example of substance-induced
Neil E, Paterson, W Connor, Darby, Preetpal S, Sandhu   +2 more
openaire   +2 more sources

Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT)

Journal of Psychoactive Drugs, 2020
This case report describes a 39-year-old male with remote history of polysubstance use disorder and depression who developed tinnitus after use of inhaled N,N-dimethyltryptamine (DMT). Although development of ear ringing was attributed to use on a single occasion, tinnitus occurred within the context of a larger self-experiment involving weekly ...
Heba Diab, Benjamin Malcolm
openaire   +2 more sources